Orthopaedic Oncology Market Growth and Forecast 2015-2025

Report Description
Orthopedic oncology accounts for a small proportion in orthopedics. Orthopedic oncology is a
condition that arises due to the formation of benign and malignant tumors in bones and
connective soft tissues. It also includes the diagnosis and treatment of patients with metastatic
carcinomato the skeleton. Bone and soft tissue tumors are quite rare and sometimes require
reconstructive surgery. Soft tissue sarcomas are more common than bone sarcomas. For 2016,
the American Cancer Society estimates about 3,300 new cases for cancer of the bones and joints
and 12,310 new cases for soft tissue sarcomas. There are three main types of bone cancers,
osteosarcoma, which arises most often in the growing ends of long bones, chondrosarcoma,
which develops in the metaphysis and Ewing’s sarcoma. Malignant bone tumors also referred to
as chondrosarcoma are more prevalent in adults than other form of cancers and remains a
challenging tumor to diagnose and treat. Treatment with chemotherapy and radiotherapy do
not remain the preferred choice of treatment in treating such type of tumor as clinical studies
demonstrate no substantial improvements in the survival rate of the patients. Therefore,
adequate surgical resection is the mainstay of treatment in case of chondrosarcoma. As
estimated by the American Cancer Society, chondrosarcomas is more prevalent with 40% of
cases developing in adults whereas less than 5% of cases occur in patients younger than 20.
Radiofrequency ablation has become the standard and most preferred choice of treatment in
case of osteoid osteoma, a benign bone tumor that arises from osteoblasts. However studies
demonstrates its expanded application in palliative treatment of patients with painful bone
metastasis.